BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 25746592)

  • 1. MicroRNA-141 is a biomarker for progression of squamous cell carcinoma and adenocarcinoma of the lung: clinical analysis of 125 patients.
    Zhang X; Li P; Rong M; He R; Hou X; Xie Y; Chen G
    Tohoku J Exp Med; 2015 Mar; 235(3):161-9. PubMed ID: 25746592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-205 and MiR-375 microRNA assays to distinguish squamous cell carcinoma from adenocarcinoma in lung cancer biopsies.
    Patnaik S; Mallick R; Kannisto E; Sharma R; Bshara W; Yendamuri S; Dhillon SS
    J Thorac Oncol; 2015 Mar; 10(3):446-53. PubMed ID: 25695220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer.
    Rakaee M; Busund LT; Paulsen EE; Richardsen E; Al-Saad S; Andersen S; Donnem T; Bremnes RM; Kilvaer TK
    Oncotarget; 2016 Nov; 7(44):72184-72196. PubMed ID: 27708229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of tumour mutation burden in patients with non-small cell lung cancer and interstitial lung disease.
    Kobayashi H; Serizawa M; Naito T; Konno H; Kojima H; Mizuno T; Isaka M; Endo M; Nagashima T; Kusuhara M; Urakami K; Ohshima K; Yamaguchi K; Ohde Y; Takahashi T
    Respirology; 2020 Aug; 25(8):850-854. PubMed ID: 31694070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Network Analysis of Patients with Non-Small Cell Lung Cancer and Smokers for Representing Potential Therapeutic Targets.
    Pazhouhandeh M; Samiee F; Boniadi T; Khedmat AF; Vahedi E; Mirdamadi M; Sigari N; Siadat SD; Vaziri F; Fateh A; Ajorloo F; Tafsiri E; Ghanei M; Mahboudi F; Rahimi Jamnani F
    Sci Rep; 2017 Oct; 7(1):13812. PubMed ID: 29062084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-Gene Signature for Differential Diagnosis and Therapeutic Decisions in Non-Small-Cell Lung Cancer-A Validation Study.
    Charkiewicz R; Sulewska A; Karabowicz P; Lapuc G; Charkiewicz A; Kraska M; Pancewicz J; Lukasik M; Kozlowski M; Stec R; Ziembicka D; Piszcz W; Miltyk W; Niklinska W
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma.
    Theelen WSME; Krijgsman O; Monkhorst K; Kuilman T; Peters DDGC; Cornelissen S; Ligtenberg MA; Willems SM; Blaauwgeers JLG; van Noesel CJM; Peeper DS; van den Heuvel MM; Schulze K
    J Transl Med; 2020 Jul; 18(1):271. PubMed ID: 32620126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classifying non-small cell lung cancer types and transcriptomic subtypes using convolutional neural networks.
    Yu KH; Wang F; Berry GJ; Ré C; Altman RB; Snyder M; Kohane IS
    J Am Med Inform Assoc; 2020 May; 27(5):757-769. PubMed ID: 32364237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative tissue analysis and role of myeloid cells in non-small cell lung cancer.
    Henick BS; Villarroel-Espindola F; Datar I; Sanmamed MF; Yu J; Desai S; Li A; Aguirre-Ducler A; Syrigos K; Rimm DL; Chen L; Herbst RS; Schalper KA
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM11 expression in non-small cell lung cancer is associated with poor prognosis.
    Kuempers C; Jagomast T; Paulsen FO; Heidel C; Bohnet S; Schierholz S; Reischl M; Dreyer E; Olchers T; Reck M; Kirfel J; Perner S
    Histol Histopathol; 2024 Apr; 39(4):437-446. PubMed ID: 37409491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota Diversity in Non-Small Cell Lung Cancer Gut and Mouth Cavity Microbiota Diversity in Non-Small Cell Lung Cancer Patients.
    Brisudová A; Bielniková-Kryštofová H; Motyka O; Fritzová D; Katuchová V; Ponikelská N; Skanderová D; Raclavský V; Michálek J; Mitták M; Švecová P; Jakubec P; Rozsivalová D; Szkorupa M; Klein J; Škarda J; Kolář Z; Skopelidou V
    Pol J Microbiol; 2023 Dec; 72(4):467-475. PubMed ID: 38103007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction uncertainty estimates elucidate the limitation of current NSCLC subtype classification in representing mutational heterogeneity.
    Puiu A; Gómez Tapia C; Weiss MER; Singh V; Kamen A; Siebert M
    Sci Rep; 2024 Mar; 14(1):6779. PubMed ID: 38514696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Report: Impact of Reflex Testing on Tissue-Based Molecular Genotyping in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.
    Marmarelis ME; Scholes DG; McGrath CM; Priore SF; Roth JJ; Feldman M; Morrissette JJD; Litzky L; Deshpande C; Thompson JC; Doucette A; Gabriel PE; Sun L; Singh AP; Cohen RB; Langer CJ; Carpenter EL; Aggarwal C
    Clin Lung Cancer; 2024 May; 25(3):262-265.e2. PubMed ID: 38582618
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular Senescence in Non-Small Cell Lung Cancer.
    Zhu H; Sun J; Zhang C; Li P; Tan C; Yang M; Zhao G
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):357. PubMed ID: 38179738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-infiltrating platelets promote the growth of lung adenocarcinoma.
    Li X; Li M; Hu Z; Zhou L; Zheng M; Jiao D; Qin J; Fu B; Zheng X; Wei H
    Transl Oncol; 2024 Jan; 39():101813. PubMed ID: 38235621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New strategies in squamous cell carcinoma of the lung: identification of tumor drivers to personalize therapy.
    Gold KA; Wistuba II; Kim ES
    Clin Cancer Res; 2012 Jun; 18(11):3002-7. PubMed ID: 22461458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strength of selection in lung tumors correlates with clinical features better than tumor mutation burden.
    Gorlov IP; Gorlova OY; Tsavachidis S; Amos CI
    Sci Rep; 2024 Jun; 14(1):12732. PubMed ID: 38831004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis.
    Zang X; Chen M; Zhou Y; Xiao G; Xie Y; Wang X
    Cancer Inform; 2015; 14(Suppl 2):183-91. PubMed ID: 26052221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of oxidized phosphocholine profile in non-small-cell lung cancer.
    Godzien J; Lopez-Lopez A; Sieminska J; Jablonowski K; Pietrowska K; Kisluk J; Mojsak M; Dzieciol-Anikiej Z; Barbas C; Reszec J; Kozlowski M; Moniuszko M; Kretowski A; Niklinski J; Ciborowski M
    Front Mol Biosci; 2023; 10():1279645. PubMed ID: 38288337
    [No Abstract]   [Full Text] [Related]  

  • 20. miR-25 targets the modulator of apoptosis 1 gene in lung cancer.
    Wu T; Chen W; Kong D; Li X; Lu H; Liu S; Wang J; Du L; Kong Q; Huang X; Lu Z
    Carcinogenesis; 2015 Aug; 36(8):925-35. PubMed ID: 25998847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.